Trial Outcomes & Findings for Assessment of Safety of Air Travel in Patients With Birt-Hogg-Dube Syndrome (NCT NCT03040115)

NCT ID: NCT03040115

Last Updated: 2024-01-31

Results Overview

The investigators will measure the number of pneumothoraces that occur either during air travel, or within 24 hours of air travel among patients with Birt-Hogg-Dube syndrome. The incidence of air travel related pneumothorax will be calculated by dividing the number of pneumothoraces to the total number of flights undertaken by the entire cohort.

Recruitment status

COMPLETED

Target enrollment

104 participants

Primary outcome timeframe

During air travel or within 24 hours following air travel

Results posted on

2024-01-31

Participant Flow

Participant milestones

Participant milestones
Measure
Patients Self-reporting With BHD
Patients self-reporting with BHD
Overall Study
STARTED
104
Overall Study
COMPLETED
104
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Patients Self-reporting With BHD
n=104 Participants
Patients self-reporting with BHD
Age, Continuous
50 years
n=104 Participants
Sex: Female, Male
Female
86 Participants
n=104 Participants
Sex: Female, Male
Male
18 Participants
n=104 Participants
Region of Enrollment
United States
104 Participants
n=104 Participants
Number of Participants with a History of Air Travel
99 participants
n=104 Participants

PRIMARY outcome

Timeframe: During air travel or within 24 hours following air travel

The investigators will measure the number of pneumothoraces that occur either during air travel, or within 24 hours of air travel among patients with Birt-Hogg-Dube syndrome. The incidence of air travel related pneumothorax will be calculated by dividing the number of pneumothoraces to the total number of flights undertaken by the entire cohort.

Outcome measures

Outcome measures
Measure
BHD Patients With Air Travel Related Pneumothorax
n=104 Participants
Air travel related pneumothorax in patients with BHD
Number of Patients With Birt-Hogg-Dube Syndrome Who Experienced Spontaneous Pneumothorax During or Within 24 Hours Following Air Travel
8 Participants

SECONDARY outcome

Timeframe: 3 years

The investigators will catalogue the number of spontaneous pneumothoraces experienced by patients with Birt-Hogg-Dube syndrome.

Outcome measures

Outcome measures
Measure
BHD Patients With Air Travel Related Pneumothorax
n=104 Participants
Air travel related pneumothorax in patients with BHD
Number of Patients With Birt-Hogg-Dube Syndrome Who Experience a Spontaneous Pneumothorax
79 Participants

SECONDARY outcome

Timeframe: 3 years

The investigators will measure the incidence of ipsilateral pneumothorax following pleurodesis in order to determine the efficacy (as measured by the rate of pneumothorax recurrence following pleurodesis).

Outcome measures

Outcome measures
Measure
BHD Patients With Air Travel Related Pneumothorax
n=79 Participants
Air travel related pneumothorax in patients with BHD
Number of Patients With Birt-Hogg-Dube Syndrome Who Experience Recurrent Pneumothorax Following Pleurodesis
29 Participants

Adverse Events

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Elizabeth Kopras, Senior Research Associate

University of Cincinnati

Phone: 513-558-7205

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place